2007
DOI: 10.1159/000104213
|View full text |Cite
|
Sign up to set email alerts
|

Cryopreservation of Hematopoietic Stem Cells: Emerging Science, Technology and Issues

Abstract: Cell therapies based on hematopoietic stem cells (HSCs) have become the standard of care for a variety of diseases, and the number of patients and disorders being treated using HSCs continues to grow. Effective methods of preservation are critical for the clinical implementation of HSC-based therapies. Preservation permits the completion of safety and quality control testing, transportation to the site of use and coordination of the therapy with patient care regimes. This review discusses advances in the basic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 75 publications
0
15
0
Order By: Relevance
“…In fact, the definition of experimental protocols, where the stepwise CPA addition and elution and even the use of automated cell washers are the subjects of research articles recently published. 11,13,39,40 On the other hand, a stepwise CPA addition/removal for the reduction of cell volume variation always implies the increase of the equilibration time. Consequently, to limit longer contact times with a cytotoxic agent that may also be lethal, 41 low temperature equilibration is currently under investigation.…”
Section: Resultsmentioning
confidence: 99%
“…In fact, the definition of experimental protocols, where the stepwise CPA addition and elution and even the use of automated cell washers are the subjects of research articles recently published. 11,13,39,40 On the other hand, a stepwise CPA addition/removal for the reduction of cell volume variation always implies the increase of the equilibration time. Consequently, to limit longer contact times with a cytotoxic agent that may also be lethal, 41 low temperature equilibration is currently under investigation.…”
Section: Resultsmentioning
confidence: 99%
“…-With safety, energy, health, and the environment issues becoming more pronounced, the utilization of chemicals in preservation processes that are not environmentally friendly or outright harmful is becoming more of an issue. Most of the cryoprotectants are extremely cytotoxic (even mutagenic) at high temperatures (such as the widely used cryoprotectant, dimethyl sulfoxide) and therefore require removal immediately after thawing [27]. This not only adds a critical procedure to be performed before the product can be used but also residual cryoprotectant left in the product causes loss of viability, and function.…”
Section: Current Stabilization Methodsmentioning
confidence: 99%
“…The development of certain technologies, e.g. volumetric rapid cooling, utilization of non-toxic and environmentally friendly stabilization agents, efficient, and safe preservation agent loading, and removal methods [27], without any doubt, will affect the stabilization field in a positive direction. Developments in the spectroscopic and molecular microscopy techniques will help us understand the mechanisms at the molecular level and predict the macroscopic outcome.…”
Section: Future Of Biostabilizationmentioning
confidence: 99%
“…Cryopreservation, as a means of longterm preservation, is generally required for this reason. 4 The widespread use of HSC treatments has resulted in an increasing demand for cryoprotective techniques and for continuous re-examination of cryoprotective practices. In the past few years, improvements have been made in bone marrow, umbilical cord blood, and peripheral blood cryopreservation techniques.…”
Section: Introductionmentioning
confidence: 99%